Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.630
-0.030 (-1.81%)
Apr 29, 2026, 9:32 AM EDT - Market open
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 81 employees as of December 31, 2025. The number of employees decreased by 22 or -21.36% compared to the previous year.
Employees
81
Change (1Y)
-22
Growth (1Y)
-21.36%
Revenue / Employee
$614,852
Profits / Employee
-$621,494
Market Cap
690.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| Absci | 140 |
| Solid Biosciences | 121 |
| BridgeBio Oncology Therapeutics | 92 |
| Forte Biosciences | 19 |
LXRX News
- 12 days ago - Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo - GlobeNewsWire
- 5 weeks ago - Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851 - GlobeNewsWire
- 6 weeks ago - Lexicon Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes - GlobeNewsWire
- 7 weeks ago - Lexicon Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences - GlobeNewsWire